Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Regeneron Pharmaceuticals (REGN.VI) Q4 2020 Earnings
REGN.VI
5
Nov
Confirmed
Q1 2020
Q2 2020
Q3 2020
Q4 2020
4.83
5.57
6.32
7.07
Details
Expected EPS
6.191256
Actual EPS
7.070887999999999
Surprise EPS
0.88
Surprise Percent
+14.21%
Description
Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 7.070887999999999 per share for Q4 2020.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login